Table 2.
Comparison of clinical outcomes and adverse reactions between Biapenem group and Meropenem group before and after matching.
| Variables, n (%) | Original cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
| Biapenem (n = 211) | Meropenem (n = 704) | p | Biapenem (n = 208) | Meropenem (n = 208) | p | |
| Effective | 190 (90.00) | 636 (90.3) | 1.0 | 188 (90.4) | 189 (90.9) | 1.0 |
| ADR | 16 (7.6) | 49 (7.0) | 0.876 | 16 (7.7) | 15 (7.2) | 1.0 |